1. K Taber,R Hurley,S Yudofsky (2010). Diagnosis and treatment of neuropsychiatric disorders. Annu Rev Med, 61, 121-133.
2. I Martins (2015). Diabetes and Organ Dysfunction in the Developing and Developed World. GJMR, 15, 15-21.
3. I Martins (2018). Branched-Chain Amino Acids: The Metabolic Link Between Type 2 Diabetes Mellitus and Cardiovascular Disease?. Circulation: Genomic and Precision Medicine, 11(6), 1-003.
4. Sunil Kota,Lalit Meher,Sruti Jammula,S Krishna,Siva Kota,Kirtikumar Modi (2012). Neuropsychiatric screening in type 2 diabetes mellitus. Indian Journal of Endocrinology and Metabolism, 16(7), 37.
5. Yatan Balhara (2011). Diabetes and psychiatric disorders. Indian Journal of Endocrinology and Metabolism, 15(4), 274.
6. Levitt Katz,L Swami,S Abraham,M Murphy,K Jawad,A (2005). Neuropsychiatric disorders at the presentation of type 2 diabetes mellitus in children. Pediatr Diabetes, 6, 84-89.
7. I Martins (2018). Genomic Medicine and Endocrine Autoimmunity as Key to Mitochondrial Disease. Glob J Endocrinol Metab, 2, 1-3.
8. D Kerr,C Krishnan,M Pucak,J Carmen (2005). The immune system and neuropsychiatric diseases. Int Rev Psychiatry, 17, 443-449.
9. Aarane Ratnaseelan,Irene Tsilioni,Theoharis Theoharides (2018). Effects of Mycotoxins on Neuropsychiatric Symptoms and Immune Processes. Clinical Therapeutics, 40(6), 903-917.
10. G Morris,M Berk (2015). The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med, 13, 68.
11. Franziska Radtke,Gareth Chapman,Jeremy Hall,Yasir Syed (2017). Modulating Neuroinflammation to Treat Neuropsychiatric Disorders. BioMed Research International, 2017, 1-21.
12. David Horrobin,A Glen,Krishna Vaddadi (1994). The membrane hypothesis of schizophrenia. Schizophrenia Research, 13(3), 195-207.
13. E Schaeffer,W Gattaz,G Eckert (2012). Alterations of Brain Membranes in Schizophrenia: Impact of Phospholipase A2. Current Topics in Medicinal Chemistry, 12(21), 2314-2323.
14. I Martins (2018). Increased Risk for Obesity and Diabetes with Neurodegeneration in Developing Countries. Journal of Molecular and Genetic Medicine, s1(01), 1-35.
15. Shivangi Patel,Dilip Sharma,Kiran Kalia,Vinod Tiwari (2017). Crosstalk between endoplasmic reticulum stress and oxidative stress in schizophrenia: The dawn of new therapeutic approaches. Neuroscience & Biobehavioral Reviews, 83, 589-603.
16. Neil Sprenkle,Savannah Sims,Cristina Sánchez,Gordon Meares (2017). Endoplasmic reticulum stress and inflammation in the central nervous system. Molecular Neurodegeneration, 12(1), 42.
17. D Lindholm,L Korhonen,O Eriksson,S Kõks (2017). Recent Insights into the Role of Unfolded Protein Response in ER Stress in Health and Disease. Front Cell Dev Biol, 5, 48.
18. Douglas Wallace (2017). A Mitochondrial Etiology of Neuropsychiatric Disorders. JAMA Psychiatry, 74(9), 863.
19. Samantha Marin,Russell Saneto (2016). Neuropsychiatric Features in Primary Mitochondrial Disease. Neurologic Clinics, 34(1), 247-294.
20. Liming Pei,Douglas Wallace (2018). Mitochondrial Etiology of Neuropsychiatric Disorders. Biological Psychiatry, 83(9), 722-730.
21. D Marazziti,S Baroni,M Picchetti,P Landi,S Silvestri,E Vatteroni,M Catena Dell'osso (2011). Mitochondrial Alterations and Neuropsychiatric Disorders. Current Medicinal Chemistry, 18(30), 4715-4721.
22. Erin Heinzen,Benjamin Neale,Stephen Traynelis,Andrew Allen,David Goldstein (2015). The Genetics of Neuropsychiatric Diseases: Looking In and Beyond the Exome. Annual Review of Neuroscience, 38(1), 47-68.
23. A Corvin,G Donohoe,A Hargreaves,L Gallagher,M Gill (2012). The Cognitive Genetics of Neuropsychiatric Disorders. Current Topics in Behavioral Neurosciences, 12, 579-613.
24. D Dick,B Riley,K Kendler (2010). Nature and nurture in neuropsychiatric genetics: where do we stand?. Dialogues Clin Neurosci, 12, 7-23.
25. Ian Martins (2016). Anti-Aging Genes Improve Appetite Regulation and Reverse Cell Senescence and Apoptosis in Global Populations. Advances in Aging Research, 05(01), 9-26.
26. I Martins (2017). Single Gene Inactivation with Implications to Diabetes and Multiple Organ Dysfunction Syndrome. J Clin Epigenet, 3, 24.
27. Carolyn Ptak,Arturas Petronis (2010). Epigenetic approaches to psychiatric disorders. Dialogues in Clinical Neuroscience, 12(1), 25-35.
28. Melissa Mahgoub,Lisa Monteggia (2013). Epigenetics and Psychiatry. Neurotherapeutics, 10(4), 734-741.
29. T Kishi,Y Fukuo,T Kitajima,T Okochi,Y Yamanouchi,Y Kinoshita,K Kawashima,T Inada,H Kunugi,T Kato,T Yoshikawa,H Ujike,N Ozaki,N Iwata (2011). SIRT1 gene, schizophrenia and bipolar disorder in the Japanese population: an association study. Genes, Brain and Behavior, 10(3), 257-263.
30. G Lu,J Li,H Zhang,X Zhao,L-J Yan (2018). Role and Possible Mechanisms of Sirt1 in Depression. Oxidative Medicine and Cellular Longevity, 1-6.
31. H-D Kim,J Hesterman,T Call,S Magazu,E Keeley,K Armenta,H Kronman,R Neve,E Nestler,D Ferguson (2016). SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens. Journal of Neuroscience, 36(32), 8441-8452.
32. Snehajyoti Chatterjee,Ted Abel (2016). To Stay Happy, Keep Your SIRT1 Active. Biological Psychiatry, 80(11), 808-809.
33. Juhyun Song,Jongpil Kim (2016). Role of Sirtuins in Linking Metabolic Syndrome with Depression. Frontiers in Cellular Neuroscience, 10, 86.
34. L Lo Iacono,F Visco-Comandini,A Valzania,M Viscomi,M Coviello,A Giampà,L Roscini,E Bisicchia,A Siracusano,A Troisi,S Puglisi-Allegra,V Carola (2015). Adversity in childhood and depression: linked through SIRT1. Translational Psychiatry, 5(9), e629-e629.
35. Naoko Abe-Higuchi,Shusaku Uchida,Hirotaka Yamagata,Fumihiro Higuchi,Teruyuki Hobara,Kumiko Hara,Ayumi Kobayashi,Yoshifumi Watanabe (2016). Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior. Biological Psychiatry, 80(11), 815-826.
36. Xiaosong Bu,De Wu,Xiaomei Lu,Li Yang,Xiaoyan Xu,Juan Wang,Jiulai Tang (2017). Role of SIRT1/PGC-1α in mitochondrial oxidative stress in autistic spectrum disorder. Neuropsychiatric Disease and Treatment, Volume 13, 1633-1645.
37. A Herskovits,Leonard Guarente (2014). SIRT1 in Neurodevelopment and Brain Senescence. Neuron, 81(3), 471-483.
38. Stanley Chan,Xuechan Zhao,Abdulsalam Elfowiris,Cherubina Ratnam,Terence Herbert (2017). The role of de novo protein synthesis and SIRT1 in ER stress-induced Atf4 and Chop mRNA expression in mammalian cells. Biochimie, 138, 156-167.
39. Tae Jung,Kyoung-Tae Lee,Myung Lee,Kang-Hyeon Ka (2012). SIRT1 attenuates palmitate-induced endoplasmic reticulum stress and insulin resistance in HepG2 cells via induction of oxygen-regulated protein 150. Biochemical and Biophysical Research Communications, 422(2), 229-232.
40. Y Li,S Xu,A Giles,K Nakamura,J Lee (2011). Hepatic over expression of SIRT1 in mice attenuates endoplasmic reticulum stress and insulin resistance in the liver. FASEB J, 25, 1664-1679.
41. Tomoaki Koga,Mary Suico,Shogo Shimasaki,Eriko Watanabe,Yukari Kai,Kosuke Koyama,Kohei Omachi,Saori Morino-Koga,Takashi Sato,Tsuyoshi Shuto,Kazutoshi Mori,Shinjiro Hino,Mitsuyoshi Nakao,Hirofumi Kai (2015). Endoplasmic Reticulum (ER) Stress Induces Sirtuin 1 (SIRT1) Expression via the PI3K-Akt-GSK3β Signaling Pathway and Promotes Hepatocellular Injury. Journal of Biological Chemistry, 290(51), 30366-30374.
42. A Prola,Da Pires,J Silva,A Guilbert,L Lecru,J Piquereau (2017). SIRT1 protects the heart from ER stress-induced cell death through eIF2α deacetylation. Cell Death Differ, 24, 343-356.
43. Ian Martins (2018). Heat Shock Gene Inactivation and Protein Aggregation with Links to Chronic Diseases. Diseases, 6(2), 39.
44. I Martins (2017). The Future of Genomic Medicine Involves the Maintenance of Sirtuin 1 in Global Populations. Int J Mol Biol, 2, 13.
45. J Martinsi (2016). Bacterial Lipopolysaccharides Change Membrane Fluidity with Relevance to Phospholipid and Amyloid Beta Dynamics in Alzheimer’s Disease. Journal of Microbial & Biochemical Technology, 8(4), 322-324.
46. Ian Martins (2015). LPS Regulates Apolipoprotein E and A<i>β</i> Interactionswith Effects on Acute Phase Proteins and Amyloidosis. Advances in Aging Research, 04(02), 69-77.
47. I Martins (2018). Appetite Regulation and the Peripheral Sink Amyloid beta Clearance Pathway in Diabetes and Alzheimer's Disease. Top 10 Commentaries in Alzheimer's Disease. Avid Science, 2, 1-11.
48. C Müller,M Reichel,C Mühle,C Rhein,E Gulbins (2015). Brain membrane lipids in major depression and anxiety disorders. Biochim Biophys Acta, 1851, 1052-1065.
49. P Kidd (2004). Bipolar disorder and cell membrane dysfunction. Progress toward integrative management. Altern Med Rev, 9, 107-135.
50. Ian Martins (2015). Overnutrition Determines LPS Regulation of Mycotoxin Induced Neurotoxicity in Neurodegenerative Diseases. International Journal of Molecular Sciences, 16(12), 29554-29573.
51. Jill Karatinos,Richard Rosse,Stephen Deutsch (1995). The Nitric Oxide Pathway. Clinical Neuropharmacology, 18(6), 482-499.
52. O Akyol,S Zoroglu,F Armutcu,S Sahin,A Gurel (2004). Nitric oxide as a physiopathological factor in neuropsychiatric disorders. In Vivo, 18, 377-390.
53. Martins Ij (2017). Antimicrobial activity inactivation and toxic immune reactions induce Epilepsy in humans. Journal of Medical Discovery, 2(4), 1-7.
54. I Martins (2015). Nutritional diets accelerate amyloid beta metabolism and prevent the induction of chronic diseases and Alzheimer's disease. Photon ebooks, 1-48.
55. Philip Harvey,Robert Heaton,William Carpenter,Michael Green,James Gold,Michael Schoenbaum (2012). Diagnosis of schizophrenia: Consistency across information sources and stability of the condition. Schizophrenia Research, 140(1-3), 9-14.
56. Assen Jablensky (2010). The diagnostic concept of schizophrenia: its history, evolution, and future prospects. Dialogues in Clinical Neuroscience, 12(3), 271-287.
57. Larry Goldman,Nancy Nielsen,Hunter Champion (1999). Awareness, diagnosis, and treatment of depression. Journal of General Internal Medicine, 14(9), 569-580.
58. A Rush (1990). Associated psychopathology in winter depression. Biological Psychiatry, 27(9), 153-154.
59. K Smith,P Renshaw,J Bilello (2013). The diagnosis of depression: current and emerging methods. Compr Psychiatry, 54, 1-6.
60. Larry Culpepper (2014). The Diagnosis and Treatment of Bipolar Disorder. The Primary Care Companion For CNS Disorders, 16
61. I Martins (2018). Sirtuin 1, a Diagnostic Protein Marker and its Relevance to Chronic Disease and Therapeutic Drug Interventions. ECPT, 6, 209-215.
62. Ian Martins (2016). Magnesium Therapy Prevents Senescence with the Reversal of Diabetes and Alzheimer’s Disease. Health, 08(07), 694-710.
63. I Martins (2017). Nutrition Therapy Regulates Caffeine Metabolism with Relevance to NAFLD and Induction of Type 3 Diabetes. J Diabetes Metab Disord, 4, 19.
64. C Tessier,K Sweers,A Frajerman,H Bergaoui,F Ferreri,C Delva,N Lapidus,A Lamaziere,J Roiser,M De Hert,P Nuss (2016). Membrane lipidomics in schizophrenia patients: a correlational study with clinical and cognitive manifestations. Translational Psychiatry, 6(10), e906-e906.
65. I Martins (2017). The Future of Biomarkers Tests and Genomic Medicine in Global Organ Disease. Microbiology and Infectious Diseases, 1, 1-6.
66. I Martins (2017). Biomarker Tests and Ageing Science. Ageing Science & Mental Health Studies, 1(1), 1-2.
67. Martin Strassnig,Jaspreet Singh Brar,Rohan Ganguli (2005). Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophrenia Research, 76(2-3), 343-351.
68. Salvatore Dipasquale,Carmine Pariante,Paola Dazzan,Eugenio Aguglia,Philip Mcguire,Valeria Mondelli (2013). The dietary pattern of patients with schizophrenia: A systematic review. Journal of Psychiatric Research, 47(2), 197-207.
69. Bryan Kraft,Eric Westman (2009). Schizophrenia, gluten, and low-carbohydrate, ketogenic diets: a case report and review of the literature. Nutrition & Metabolism, 6(1), 10.
70. Sathyanarayana Rao,T Asha,M Ramesh,B,Jagannatha Rao,K (2008). Understanding nutrition, depression and mental illnesses. Indian J Psychiatry, 50, 77-82.
71. Ian Martins (2017). Functional Foods and Active molecules with relevance to Health and Chronic disease. Functional Foods in Health and Disease, 7(10), 849.
72. I Martins (2015). Unhealthy Nutrigenomic Diets Accelerate NAFLD and Adiposity in Global communities. Journal of Molecular and Genetic Medicine, 09(01), 1-8.
